Health care IT provider of online patient engagement and analytics solutions for hospital systems

Healthgrades (formerly “Influence Health” and “MEDSEEK”) helps hospitals, health systems, clinicians and ACOs virtually influence prospects and patients before and after the clinical encounter. The Healthgrades platform integrates web, mobile, social, predictive analytics and relationship management solutions to help organizations drive profitable volume, improve individual and population health, increase patient satisfaction and create lasting health-related loyalty. The company’s comprehensive software products enable healthcare organizations to meet patients where they are and engage them in new and better ways. In 2013 the company acquired SymphonyCare, a leading care management software platform that will accelerate Influence Health’s entry into the population health management space and expand the company’s patient engagement platform. Healthgrades is uniquely positioned to capitalize on a variety of ongoing changes in the healthcare industry and the shift towards population health management and quality-based care reimbursement models. Based in Denver, Colorado, Healthgrades serves 200+ customers representing over 1,000 hospitals, including many of the hospital systems in the United States and Canada. Healthgrades acquired InfluenceHealth in January 2019.

  • Denver, CO

  • Contact:
  • Formerly Known As: Influence Health
  • Acquisition
  • Acquired by: Mercury Healthcare
  • Exit date: August 04, 2021

Related News

“The expertise, support and collaborative approach that Essex Woodlands provides have helped Influence Health enhance our solutions and expand our integrated patient influence platform. Our technology gives healthcare organizations the power to influence decisions and behaviors, improving patient care and population health.”

Peter Kuhn

President and Chief Customer Officer

Testimonials and endorsements reflect portfolio company management’s opinions and beliefs regarding the company and the investment. Such opinions and beliefs are subjective, do not represent a complete assessment of the company, the market or EW’s overall investment performance and cannot be independently verified. Such statements are being offered as references for purposes of demonstrating the benefits of working with the EW team and not for the purpose of soliciting investors. Portfolio company executives receive/received a salary and economics from the portfolio company. No executives were paid for their testimonial or endorsement. There is a conflict of interest in these unpaid testimonials and endorsements in that all speakers stand to benefit from EW’s success and they work/worked for an EW portfolio company.